Contrast-Enhanced Power Doppler Sonography in Breast Lesions: Effect on Differential Diagnosis after Mammography and Gray Scale Sonography

Journal of Ultrasound in Medicine

Volumn 23, Issue 2, 2004, Pages 183-196

  Özdemir, Ayşegül ^a,c   Kiliç, Koray ^a   Özdemir, Hakan ^a   Yücel, Cem ^a   Andaç, Şebnem ^a   Çolak, Meriç ^b  

^a Gazi 5 University   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c University Hospital of Gazi   (Turkey)

Author keywords

Breast neoplasms, diagnosis; Breast neoplasms, sonography; Sonography, contrast media; Sonography, power Doppler studies

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; CLASSIFICATION (OF INFORMATION); DOPPLER EFFECT; MAMMOGRAPHY; RADIOLOGY; SONOLUMINESCENCE; TUMORS;

SONOGRAPHY;

ULTRASONIC IMAGING;

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST BIOPSY; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER THERAPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; DRUG EFFICACY; ECHOMAMMOGRAPHY; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; INJECTION; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; OBSERVER VARIATION; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARIZATION;

EID: 1042266596     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2004.23.2.183     Document Type: Article

References (21)

1. Zonderland HM, Coerkamp EG, Hermans J, et al. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 1999; 213:413-422.
2. Moss HA, Britton PD, Flower CD, et al. How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population? Clin Radiol 1999; 54:676-682.
3. Gordon PB, Goldenberg SL, Chan NHL. Solid breast lesions: diagnosis with US-guided fine needle aspiration biopsy. Radiology 1993; 189:573-580.
4. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US. Diagnostic yield and tumor characteristics. Radiology 1998; 207:188-191.
5. Ozdemir A, Oznur II, Vural G, et al. TI-201 scintigraphy, mammography, and ultrasonography in the evaluation of palpable and nonpalpable breast lesions: a correlative study. Eur J Radiol 1997; 24:145-154.
6. Van Dam PA, van Goethem MLA, Kersschot E, et al. Palpable solid breast masses: retrospective single and multimodality evaluation of 201 lesions. Radiology 1988; 166:435-439.
7. Özdemir A, Özdemir H, Maral I, Konuş O, Yücel S, Işik S. Differential diagnosis of solid breast lesions: contribution of Doppler studies to mammography and gray scale imaging. J Ultrasound Med 2001; 20:1091-1101.
8. Stuhrmann M, Aronius R, Schietzel M. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. AJR Am J Roentgenol 2000; 175:1585-1589.
9. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). 3rd ed. Reston, VA: American College of Radiology; 1998.
10. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123-134.
11. Rahbar G, Sie AC, Hansen GC, et al. Benign versus malignant solid breast masses: US differentiation. Radiology 1999; 213:889-894.
12. Moon WK, Im J, Noh D, Han MC. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience. Radiology 2000; 217:240-246.
13. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 1996; 198:679-686.
14. SPSS Inc. SPSS Base 11.0 User's Guide. Chicago, IL: SPSS Inc; 2001:405.
15. Harvey CJ, Blomley MJK, Eckersley RJ, Cosgrove DO. Developments in ultrasound contrast media. Eur Radiol 2001; 11:675-689.
16. Huber S, Helbich T, Kettenbach J, Dock W, Zuna I, Delorme S. Effects of microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US-early experience. Radiology 1998; 208:485-489.
17. Albrecht T, Patel N, Cosgrove DO, Jayaram V, Blomley MJK, Eckersley R. Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion. Acad Radiol 1998; 5(suppl):195-198.
18. Schroeder RJ, Maeurer J, Vogl TJ, et al. D-Galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions. Invest Radiol 1999; 34:109-115.
19. Winehouse J, Douek M, Holz K, et al. Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence. Br J Surg 1999; 86:1198-1201.
20. Alamo L, Fischer U. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI. Eur Radiol 2001; 11:970-977.
21. Yang WT, Metreweli C, Lam PK, Chang J. Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power Doppler US. Radiology 2001; 220:795-802.